Dr. Parulekar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1161 21st Avenue South
T-1218 Medical North
Nashville, TN 37232
Education & Training
- IU Kelley School of BusinessMBA, 2018 - 2020
- Baylor College of Medicine School of Biomedical SciencesMS, 2013 - 2017
- Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2007
- University of Missouri Kansas City School of MedicineClass of 2004
- University of Missouri - Kansas CityB.A., 2003
Certifications & Licensure
- TX State Medical License 2010 - 2025
- TN State Medical License 2019 - 2022
- AL State Medical License 2020 - 2020
- MO State Medical License Active through 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- Burnout Syndrome in Lung Transplant Physicians.Christina C Kao, Gloria W Li, Amit D Parulekar
Clinical Medicine & Research. 2023-06-01 - 2 citationsComparison of four commercial EBV DNA quantitative tests to a new test at an early stage of development.Evelyn Stelzl, Harald H Kessler, Amit D Parulekar, Carolin Bier, Dominik Nörz
Journal of Clinical Virology. 2023-04-01 - 9 citationsEmphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.Vickram Tejwani, Ashraf Fawzy, Nirupama Putcha, Peter J. Castaldi, Michael H. Cho
Chest. 2021-10-01
Press Mentions
- © Journal of Thoracic Disease. All Rights Reserved. J Thorac Dis 2019;11(Suppl 14):S1782-S1788 | http://dx.doi.org/10.21037/jtd.2019.05.60April 2nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: